IV Iron Infusion at Home: Feraheme, Injectafer, and Iron Deficiency Anemia Treatment

June 12, 2026

Iron deficiency anemia is one of the most common nutritional deficiencies worldwide, and for many patients, particularly those with chronic kidney disease, inflammatory bowel disease, heart failure, or post-surgical blood loss, oral iron supplements are either ineffective, poorly tolerated, or contraindicated. Intravenous iron therapy offers rapid, complete iron repletion and is now available as a home infusion service for appropriate patients.


Pharmko provides IV iron infusion as part of our home infusion therapy services across 22+ states. Our clinical team coordinates with your physician to match you with the right iron product and infusion schedule for your diagnosis and clinical profile.


Why IV Iron Instead of Oral Supplements?


Oral iron is the first-line treatment for iron deficiency, but it fails a significant portion of patients:

  • Patients with CKD on dialysis absorb oral iron poorly and frequently require IV supplementation to maintain hemoglobin targets
  • IBD patients have inflamed GI mucosa that limits oral iron absorption and can worsen GI symptoms
  • Patients with functional iron deficiency (adequate iron stores but impaired mobilization) do not respond to oral therapy
  • Post-bariatric surgery patients have reduced absorptive surface area
  • Patients who require rapid iron repletion before surgery or during pregnancy cannot achieve adequate levels with oral iron alone


IV iron bypasses the GI tract entirely, delivering iron directly to transferrin in the bloodstream for immediate use by erythropoiesis and tissue storage.


IV Iron Products Used in Home Infusion


Feraheme (ferumoxytol)


Feraheme allows large doses (510 mg) to be administered quickly, over just 15 minutes per infusion, making it one of the most efficient IV iron options for patients who need rapid repletion. It is FDA-approved for iron deficiency anemia in adults with CKD and for any adult patient with intolerance to oral iron or unsatisfactory response. Two infusions given 3 to 8 days apart complete a full 1,020 mg course.


Injectafer (ferric carboxymaltose)


Injectafer delivers up to 750 mg per infusion over 15 minutes, with a maximum of two doses per course given at least 7 days apart. It is approved broadly for iron deficiency anemia in adults who have had an unsatisfactory response to oral iron or cannot tolerate it, and for non-dialysis-dependent CKD. A notable side effect is transient hypophosphatemia, which your physician will monitor.


Venofer (iron sucrose) and Ferrlecit (sodium ferric gluconate)


These older formulations are delivered in smaller doses over longer infusions and are commonly used in dialysis patients. They are typically administered at the dialysis clinic rather than at home, but can be scheduled as home infusions in select clinical situations.


Who Qualifies for Home IV Iron Infusion?


Your physician determines whether home IV iron is appropriate based on your diagnosis, hemoglobin and ferritin levels, prior treatment history, and clinical stability. Candidates typically include:


  • CKD patients (dialysis and non-dialysis) with iron deficiency anemia not controlled by oral iron
  • IBD patients (Crohn's disease, ulcerative colitis) with chronic GI blood loss and iron malabsorption
  • Heart failure patients with functional iron deficiency affecting exercise tolerance
  • Pregnant patients with severe iron deficiency not responding to oral supplements (after first trimester)
  • Post-surgical or post-bariatric patients requiring iron repletion before recovery is complete


What to Expect During a Home Iron Infusion


A Pharmko nurse visits your home, prepares the infusion, and monitors you throughout the session. The nurse takes baseline vital signs, remains present during the infusion, and checks your vitals again before departing. Most iron infusions take between 15 minutes and 1 hour depending on the product and dose.


Rare but serious reactions, including hypersensitivity reactions, can occur with IV iron, which is why nursing supervision is required. Your nurse will watch for flushing, chest tightness, difficulty breathing, or dizziness. Know which symptoms require an immediate call after your infusion, and save our after-hours support number before your first dose.


Insurance Coverage for Home IV Iron


IV iron therapy is covered by Medicare Part B, Medicaid, and most commercial insurance plans when medical necessity is documented. Coverage criteria vary by product and diagnosis. Pharmko manages the prior authorization process and will confirm your coverage before the first infusion.


Refer a patient or contact Pharmko: 1-877-540-2003


Myasthenia Gravis and IVIG: What Patients Need to Know About IV Therapy
July 20, 2026
Learn how IVIG therapy works for myasthenia gravis, when it's used, what to expect during infusions, how home IVIG is coordinated, and how Pharmko supports MG patients and their neurologists.
Dobutamine and Inotrope Therapy at Home
July 17, 2026
Learn how home dobutamine infusion works for advanced heart failure, who qualifies, how continuous inotrope therapy is managed at home, and how Pharmko supports cardiac patients and heart failure teams.
CIDP and Home Infusion: IVIG Treatment, Dosing Schedule, and Long-Term Management
July 16, 2026
Learn how IVIG therapy works for CIDP, what the dosing schedule looks like, how to transition to home infusion, and how Pharmko supports long-term CIDP management across 22+ states.
Compounded IV Medications
July 15, 2026
Most medications that patients receive at a hospital or pharmacy come in standardized, commercially manufactured forms, a 500mg antibiotic vial, a pre-filled syringe, a fixed-concentration IV bag. These products work well for many patients. But a significant portion of patients receiving IV therapy have clinical needs that commercial products cannot meet: a dose the manufacturer doesn't make, a formulation incompatible with the patient's allergy profile, or a combination of nutrients that must be tailored to individual lab values. For these patients, compounded IV medications are not optional, they are clinically necessary. Pharmko's sterile compounding services prepare customized IV medications for patients across 22+ states, with every formulation reviewed by a licensed pharmacist and prepared in a USP <797> compliant cleanroom. What Makes an IV Medication 'Compounded'? A compounded medication is one that is prepared specifically for an individual patient by a licensed pharmacist, rather than manufactured in bulk by a pharmaceutical company. Compounding involves combining, mixing, or altering ingredients, active pharmaceutical ingredients, diluents, preservatives, to create a final preparation that meets the patient's unique prescription requirements. For IV therapy specifically, compounding means preparing a sterile preparation, one that is completely free of viable microorganisms and safe to inject or infuse directly into the bloodstream. This requires specialized facilities, equipment, training, and quality systems that go far beyond what a standard retail pharmacy can provide. Pharmko is exclusively a sterile compounding pharmacy. We do not compound oral medications, topical creams, or non-sterile preparations. Every product we make is intended for intravenous, intraperitoneal, or subcutaneous administration. When Are Compounded IV Medications Necessary? The required dose doesn't exist commercially Pharmaceutical manufacturers produce medications in standardized strengths and volumes based on average patient needs. Pediatric patients, patients with renal or hepatic impairment requiring dose adjustments, or patients whose weight or clinical status falls outside standard ranges may need concentrations or volumes that no commercial product provides. Compounding fills this gap precisely. The patient has an allergy to a commercial formulation's inactive ingredients Commercial IV products often contain preservatives, stabilizers, or diluents, sulfites, benzyl alcohol, certain dyes, that some patients cannot tolerate. A compounding pharmacy can prepare an equivalent formulation without the offending ingredient, allowing the patient to receive the therapy safely. The medication requires individualized nutrient formulation Total parenteral nutrition (TPN) is the clearest example: every TPN formula must be individually compounded because no commercial product can provide the precise combination of amino acids, dextrose, lipids, electrolytes, vitamins, and trace minerals a specific patient needs. The formula changes as the patient's labs, weight, and clinical status change, making standardization impossible. The commercial product is unavailable or in shortage Drug shortages are a persistent reality in the US pharmaceutical supply chain. When a commercially manufactured IV medication becomes unavailable, compounding pharmacies can often prepare an equivalent formulation from available active pharmaceutical ingredients, bridging the gap and maintaining continuity of therapy for patients who cannot wait. The therapy requires a custom delivery format Some IV medications require specific pH, osmolarity, or concentration adjustments for compatibility with a patient's IV access device or concurrent medications. A compounding pharmacist reviews compatibility and prepares formulations that are safe and stable for the specific administration route and equipment the patient is using. How Compounded IV Medications Are Made Step 1: Prescription review Every compounded IV medication begins with a valid prescription from a licensed prescriber. Pharmko's pharmacists review the prescription for clinical appropriateness, dosing accuracy, ingredient compatibility, and stability before compounding begins. Step 2: Ingredient sourcing and verification Active pharmaceutical ingredients for compounding must come from FDA-registered suppliers and meet USP monograph specifications. Each lot is verified for identity, potency, and purity before use. Step 3: Sterile preparation in a controlled environment Preparation occurs in an ISO Class 5 laminar airflow workbench or biological safety cabinet, located within a buffer room that meets ISO Class 7 air quality standards. Pharmacy technicians follow validated, written procedures for each preparation type, using aseptic technique to prevent contamination at every step. Step 4: Pharmacist verification and release A licensed pharmacist performs a final check of every preparation, verifying appearance, volume, labeling, and documentation, before the product is released. High-risk or complex preparations may undergo sterility testing with defined beyond-use dates based on test results. Step 5: Cold-chain delivery Most compounded IV medications require refrigeration. Pharmko uses validated cold-chain packaging and delivery logistics to ensure products arrive within their stability windows and remain temperature-controlled until the patient uses them. Quality Standards That Matter Not all compounding pharmacies operate at the same standard. The relevant quality benchmarks for sterile compounding are: USP <797> compliance, the national standard for sterile compounding environments, personnel, and processes. Our guide on USP <797> and USP <800> explains what compliance means in practice ACHC accreditation, independent third-party verification that Pharmko meets clinical quality standards for home infusion and sterile compounding State pharmacy board licensure, Pharmko is licensed in every state where we serve patients Environmental and personnel monitoring, documented air and surface sampling, personnel gowning competency assessments, and media fill testing at defined intervals For a foundational overview of what sterile compounding is and how it differs from retail pharmacy, see our guide on what is sterile compounding for IV therapy . → Contact Pharmko about compounded IV medications: 1-877-540-2003
home infusion therapy Pennsylvania
July 14, 2026
Pharmko provides home infusion therapy across Pennsylvania, IV antibiotics, IVIG, TPN, biologics, and specialty medications. Licensed, ACHC accredited, and available 24/7 statewide.
Home Infusion Therapy in New Jersey
July 14, 2026
Pharmko provides home infusion therapy across New Jersey, IV antibiotics, IVIG, TPN, IDPN, biologics, and more. Licensed, ACHC accredited, and available 24/7 statewide.
Renal dietitian reviewing albumin labs for a peritoneal dialysis patient
July 10, 2026
When to consider IPN for peritoneal dialysis patients with low albumin: clinical criteria, the stepwise nutrition approach, and the referral process.
Nephrologist reviewing dialysis nutrition options for an ESRD patient
July 10, 2026
IPN vs. IDPN explained: how each parenteral nutrition therapy works, who qualifies, and how to choose the right option for ESRD dialysis patients.
How Home Infusion Reduces Hospital Readmissions
July 10, 2026
Home infusion therapy is associated with lower hospital readmission rates, fewer complications, and significant cost savings. Review the clinical evidence and learn how Pharmko supports discharge planning teams.
Primary Immune Deficiency and IVIG: A Guide for Newly Diagnosed Patients
July 8, 2026
Newly diagnosed with primary immune deficiency? Learn how IVIG therapy works, what to expect from your first infusions, how home IVIG is coordinated, and how Pharmko supports PID patients long-term.
Show More